Centre Hospitalier Universitaire de Montpellier CHU Montpellier - Hopital Arnaud de Villeneuve

Montpellier 34295

0 studies enrolling now · 1 studies all time

What they study most

Hodgkin Disease, Lymphoma, Non-Hodgkin

Studies at this site

• A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma — Stopped early